XBiotech Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 76.3% | 85.2% | 89.4% | 42.7% | 47.5% | 30.1% | 24.6% | 23.2% | 42.6% | 13.5% | 12.8% | 5.3% | – | – | – | 16.6% | 16.6% | – | – | – | 51.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 23.7% | 14.8% | 10.6% | 57.3% | 52.5% | 69.9% | 75.4% | 76.8% | 57.4% | 86.5% | 87.2% | 94.7% | – | – | – | -16.6% | -16.6% | – | – | – | -51.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.1% | 16.6% | 22.2% | 65.7% | 95.5% | 204.5% | 123.9% | 195.2% | 1,363.6% | 679.3% | 417.5% | 2,439.0% | – | – | – | 297.9% | 375.0% | – | – | – | 1,340.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 31.7% | 40.3% | 32.7% | 85.1% | 30.2% | 99.8% | 34.1% | 41.5% | 262.8% | 197.6% | 50.0% | 376.3% | – | – | – | 29.9% | 39.2% | – | – | – | 222.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 40.8% | 56.9% | 54.9% | 150.7% | 125.8% | 304.3% | 158.0% | 236.6% | 1,626.4% | 876.9% | 467.5% | 2,815.3% | – | – | – | 311.2% | 414.2% | – | – | – | 1,562.9% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -17.1% | -42.0% | -44.3% | -93.4% | -73.3% | -234.4% | -82.6% | -159.9% | -1,569.0% | -790.5% | -380.3% | -2,720.7% | – | – | – | -327.7% | -414.2% | – | – | – | -1,562.9% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 20.2% | 15.8% | 230.2% | 1,590.0% | – | – | – | 125.6% | 125.6% | – | – | – | 10.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.9% | -46.3% | -30.3% | -39.7% | -62.8% | -214.2% | -111.9% | -170.4% | -1,290.8% | -931.5% | -610.5% | -875.0% | – | – | – | -180.7% | -380.8% | – | – | – | -1,252.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.8% | -2.1% | -6.3% | -4.8% | -9.8% | -101.1% | -39.7% | -26.7% | -211.8% | -170.5% | 142.9% | 192.7% | – | – | – | -3.8% | 1.0% | – | – | – | 3.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.1% | -44.2% | -23.9% | -34.9% | -52.9% | -113.1% | -72.2% | -143.7% | -1,079.0% | -761.0% | -753.5% | -1,067.7% | – | – | – | -176.9% | -381.8% | – | – | – | -1,255.4% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -12.7% | -38.5% | -39.1% | -82.3% | -60.5% | -200.1% | -96.7% | -154.8% | -1,148.8% | -884.0% | -566.8% | -727.3% | – | – | – | -164.1% | -356.7% | – | – | – | -1,190.9% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.